T-cell-mediated hypersensitivity to lumacaftor and ivacaftor in cystic fibrosis. (2022)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/pai.13815
PubMed Identifier: 35754124
Publication URI: http://europepmc.org/abstract/MED/35754124
Type: Journal Article/Review
Volume: 33
Parent Publication: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Issue: 6
ISSN: 0905-6157